Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

19
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

18
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

25
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
Vascular Resistance01:20

Vascular Resistance

5.0K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
5.0K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

43
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
43
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

439
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
439

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Lower LDL-c/ApoB ratio is associated with adverse cardiovascular outcomes and advanced peripheral artery disease.

VASA. Zeitschrift fur Gefasskrankheiten·2026
Same author

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026
Same author

Prognostic Significance of Electrocardiographic Findings in Hemodynamically Stable Patients With Acute Pulmonary Embolism: Insights From the RIETE Registry.

Archivos de bronconeumologia·2026
Same author

Downhill-walking exercise training in a patient with symptomatic peripheral artery disease: A case report.

Vascular medicine (London, England)·2026
Same author

Outcomes and predictors of complications after distal deep vein thrombosis: a prospective analysis of 8488 patients.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Peripheral artery disease: time to recognize the systemic burden and reorganize care.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Aug 29, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Vascular risk assessment and management.

Paola Bigolin1,2, Beniamino Zalunardo1, Lucia Mazzolai3,4,5

  • 1Angiology Unit, Azienda ULSS 2 Marca Trevigiana, Castelfranco Veneto, Italy.

VASA. Zeitschrift Fur Gefasskrankheiten
|September 6, 2022
PubMed
Summary

This study introduces an integrated care pathway model to aid healthcare professionals in managing atherosclerotic cardiovascular disease. It enhances clinical decision-making for cardiovascular risk stratification, particularly for high-risk patients.

Keywords:
Cardiovascular riskclinical pathwaysstratificationvascular medicinevascular prevention

More Related Videos

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

5.8K
Non-invasive Assessment of Microvascular and Endothelial Function
05:41

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

16.3K

Related Experiment Videos

Last Updated: Aug 29, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K
A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
07:02

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

Published on: May 15, 2020

5.8K
Non-invasive Assessment of Microvascular and Endothelial Function
05:41

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

16.3K

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Practice Guidelines

Background:

  • Atherosclerotic cardiovascular disease is a primary global cause of illness and death.
  • Effective management strategies are crucial for reducing morbidity and mortality.
  • Implementing evidence-based guidelines into clinical practice remains a challenge.

Purpose of the Study:

  • To provide a decision-making tool for health professionals in daily practice.
  • To facilitate the implementation of clinical guidelines for cardiovascular disease.
  • To improve the management of atherosclerotic cardiovascular disease.

Main Methods:

  • Development of an integrated care pathway (ICP) model.
  • Incorporation of European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Guidelines.
  • Utilizing algorithms for multifactorial cardiovascular risk evaluation and stratification.

Main Results:

  • The ICP model supports multifactorial global cardiovascular risk assessment.
  • It provides revised cardiovascular risk stratification, focusing on high- and very-high-risk patients.
  • The model aligns with current ESC/EAS guidelines.

Conclusions:

  • Multidimensional and integrated actions are key to minimizing cardiovascular disease impact.
  • The ICP aims to enhance the quality and consistency of vascular prevention.
  • Implementation leads to more optimal clinical decisions for cardiovascular health.